Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Downgrades Applied Molecular to Market Perform, Lowers Price Target to $2

SVB Leerink analyst Joseph Schwartz downgrades Applied Molecular (NASDAQ:AMTI) from Outperform to Market Perform and lowers the price target from $15 to $2.
byBenzinga Newsdesk
December 27, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Joseph Schwartz downgrades Applied Molecular (NASDAQ:AMTI) from Outperform to Market Perform and lowers the price target from $15 to $2.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts